After a decade of intravesical vanilloid therapy: still more questions than answers.
Vanilloid sensitivity is a functional signature of a subset of unmyelinated fibres innervating the urinary bladder. The role that these nerves have in the physiological control of storage and voiding is unclear. However, after the bladder has been disconnected by spinal injury from the pontine micturition centre, vanilloid-sensitive fibres assume a central role in the reflex emptying of the bladder that occurs at low volumes. Intravesical vanilloid (capsaicin or resiniferatoxin) administration is beneficial in this disorder by "desensitising" these nerves. Resiniferatoxin is superior to capsaicin in terms of its tolerability profile. Investigators are moving rapidly to identify the mechanisms by which desensitisation to vanilloids occurs. Vanilloids induce lasting, but fully reversible, changes in gene expression, including downregulation of the vanilloid receptor subtype 1. It is hoped that application of gene chip technologies will address the global profile of vanilloid-induced changes in gene expression and their relative contribution to desensitisation. Drugs that target signalling mechanisms that bring about these changes in gene expression have obvious therapeutic potential.
Szallasi
Arpad
A
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA. aszallasi@path.wustl.edu
Fowler
Clare J
CJ
D000283:Administration, Intravesical; D000818:Animals; D063385:Cannabinoid Receptor Modulators; D002211:Capsaicin / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use*; D005231:Fatty Acids, Unsaturated / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D011955:Receptors, Drug / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*; D001745:Urinary Bladder Diseases / Q000188:drug therapy* / Q000378:metabolism
D063385:Cannabinoid Receptor Modulators; D005231:Fatty Acids, Unsaturated; D011955:Receptors, Drug; D002211:Capsaicin